Mary K Dahmer1, Heidi Flori1, Anil Sapru2, Joseph Kohne1, Heidi M Weeks3, Martha A Q Curley4, Michael A Matthay5, Michael W Quasney6. 1. Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI. 2. Department of Pediatrics, University of California, Los Angeles, CA. 3. Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI. 4. Department of Family and Community Health (School of Nursing), Division of Anesthesia and Critical Care Medicine (Perelman School of Medicine) University of Pennsylvania, and the Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA. 5. Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, CA. 6. Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI. Electronic address: mquasney@med.umich.edu.
Abstract
BACKGROUND: Elevated surfactant protein D (SP-D) is a relatively specific indicator of lung injury and is associated with both acute and chronic lung disease in adults and respiratory distress syndrome in premature infants. The relationship between plasma SP-D and lung injury in children with acute respiratory failure is unclear. RESEARCH QUESTION: Is plasma SP-D associated with lung injury or outcome in children with acute respiratory failure? STUDY DESIGN AND METHODS: This was a prospective cohort study in children 2 weeks to 17 years of age with acute respiratory failure who participated in the BALI multi-center study. Analyses were done using SP-D levels in plasma from the first sample taken on either the day of intubation or one of the following 2 days. SP-D level was measured by enzyme-linked immunosorbent assay. RESULTS: Plasma samples from 350 patients were used in the analysis; 233 had pediatric ARDS (PARDS). SP-D levels varied across primary diagnoses (P < .001). Elevated SP-D levels were associated with severe PARDS after adjusting for age, pediatric risk of mortality III (PRISM-III), and primary diagnosis (OR = 1.02; CI = 1.01-1.04; P = .011). Multivariable analyses also indicated that elevated SP-D levels were associated with death (OR = 1.02; CI = 1.01-1.04; P = .004), duration of mechanical ventilation (P = .012), PICU length of stay (P = .019), and highest oxygenation index (P = .040). SP-D levels also correlated with age (rs = 0.16, P = .002). INTERPRETATION: Elevated plasma SP-D levels are associated with severe PARDS and poor outcomes in children with acute respiratory failure. Future studies will determine whether SP-D can be used to predict the degree of lung injury or response to treatment and whether SP-D is useful in identifying PARDS endotypes.
BACKGROUND: Elevated surfactant protein D (SP-D) is a relatively specific indicator of lung injury and is associated with both acute and chronic lung disease in adults and respiratory distress syndrome in premature infants. The relationship between plasma SP-D and lung injury in children with acute respiratory failure is unclear. RESEARCH QUESTION: Is plasma SP-D associated with lung injury or outcome in children with acute respiratory failure? STUDY DESIGN AND METHODS: This was a prospective cohort study in children 2 weeks to 17 years of age with acute respiratory failure who participated in the BALI multi-center study. Analyses were done using SP-D levels in plasma from the first sample taken on either the day of intubation or one of the following 2 days. SP-D level was measured by enzyme-linked immunosorbent assay. RESULTS: Plasma samples from 350 patients were used in the analysis; 233 had pediatric ARDS (PARDS). SP-D levels varied across primary diagnoses (P < .001). Elevated SP-D levels were associated with severe PARDS after adjusting for age, pediatric risk of mortality III (PRISM-III), and primary diagnosis (OR = 1.02; CI = 1.01-1.04; P = .011). Multivariable analyses also indicated that elevated SP-D levels were associated with death (OR = 1.02; CI = 1.01-1.04; P = .004), duration of mechanical ventilation (P = .012), PICU length of stay (P = .019), and highest oxygenation index (P = .040). SP-D levels also correlated with age (rs = 0.16, P = .002). INTERPRETATION: Elevated plasma SP-D levels are associated with severe PARDS and poor outcomes in children with acute respiratory failure. Future studies will determine whether SP-D can be used to predict the degree of lung injury or response to treatment and whether SP-D is useful in identifying PARDS endotypes.
Authors: Carolyn S Calfee; Kevin Delucchi; Polly E Parsons; B Taylor Thompson; Lorraine B Ware; Michael A Matthay Journal: Lancet Respir Med Date: 2014-05-19 Impact factor: 30.700
Authors: Zhiguo Zhao; Nancy Wickersham; Kirsten N Kangelaris; Addison K May; Gordon R Bernard; Michael A Matthay; Carolyn S Calfee; Tatsuki Koyama; Lorraine B Ware Journal: Intensive Care Med Date: 2017-06-07 Impact factor: 17.440
Authors: David A Todd; Michael J Marsh; Anne George; Neil G Henderson; Heather Barr; Seby Sebastian; Graeme T Clark; Grielof Koster; Howard W Clark; Anthony D Postle Journal: Pediatr Crit Care Med Date: 2010-01 Impact factor: 3.624
Authors: Jens-Ulrik S Jensen; Theis S Itenov; Katrin M Thormar; Lars Hein; Thomas T Mohr; Mads H Andersen; Jesper Løken; Hamid Tousi; Bettina Lundgren; Hans Christian Boesen; Maria E Johansen; Sisse R Ostrowski; Pär I Johansson; Jesper Grarup; Jørgen Vestbo; Jens D Lundgren Journal: Ann Intensive Care Date: 2016-11-21 Impact factor: 6.925
Authors: Heidi Flori; Anil Sapru; Michael W Quasney; Ginny Gildengorin; Martha A Q Curley; Michael A Matthay; Mary K Dahmer Journal: Crit Care Date: 2019-04-17 Impact factor: 9.097
Authors: Michael A Matthay; Rachel L Zemans; Guy A Zimmerman; Yaseen M Arabi; Jeremy R Beitler; Alain Mercat; Margaret Herridge; Adrienne G Randolph; Carolyn S Calfee Journal: Nat Rev Dis Primers Date: 2019-03-14 Impact factor: 52.329
Authors: Shan L Ward; Mary K Dahmer; Heidi M Weeks; Anil Sapru; Michael W Quasney; Martha A Q Curley; Kathleen D Liu; Michael A Matthay; Heidi R Flori Journal: Pediatr Pulmonol Date: 2020-08-07
Authors: Arindam Chakrabarti; Allen Nguyen; Margaret M Newhams; Maikke B Ohlson; Xiaoying Yang; Sheila Ulufatu; Shannon Liu; Summer Park; Min Xu; Jenny Jiang; Wendy G Halpern; Veronica G Anania; Jacqueline M McBride; Carrie M Rosenberger; Adrienne G Randolph Journal: Pediatr Pulmonol Date: 2021-12-07
Authors: Matt S Zinter; A Birgitta Versluys; Caroline A Lindemans; Madeline Y Mayday; Gustavo Reyes; Sara Sunshine; Marilynn Chan; Elizabeth K Fiorino; Maria Cancio; Sabine Prevaes; Marina Sirota; Michael A Matthay; Sandhya Kharbanda; Christopher C Dvorak; Jaap J Boelens; Joseph L DeRisi Journal: Sci Transl Med Date: 2022-03-09 Impact factor: 19.319
Authors: Michelle J Lim; Matt S Zinter; Lucia Chen; Kayley Man Yee Wong; Anoopindar Bhalla; Kinisha Gala; Mona Guglielmo; Mustafa Alkhouli; Leanna L Huard; Mark R Hanudel; Sitaram Vangala; Andreas Schwingshackl; Michael Matthay; Anil Sapru Journal: Crit Care Med Date: 2021-10-25 Impact factor: 9.296
Authors: Erin F Carlton; Heidi M Weeks; Mary K Dahmer; Michael W Quasney; Anil Sapru; Martha A Q Curley; Heidi R Flori Journal: Crit Care Explor Date: 2021-07-13
Authors: Daniele De Luca; Paola Cogo; Martin C Kneyber; Paolo Biban; Malcolm Grace Semple; Jesus Perez-Gil; Giorgio Conti; Pierre Tissieres; Peter C Rimensberger Journal: Crit Care Date: 2021-02-22 Impact factor: 9.097